Pericardial fat volume correlates with inflammatory markers: The framingham heart study

Obesity

Volumn 18, Issue 5, 2010, Pages 1039-1045

  Tadros, Thomas M ^a,b   Massaro, Joseph M ^a,c   Rosito, Guido A ^d   Hoffmann, Udo ^d   Vasan, Ramachandran S ^a,e   Larson, Martin G ^a,f   Keaney Jr , John F ^g   Lipinska, Izabella ^g   Meigs, James B ^d   Kathiresan, Sekar ^d   O'Donnell, Christopher J ^a,d   Fox, Caroline S ^a,h   Benjamin, Emelia J ^a,b,c,d  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Boston University   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BODY MASS; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; ORGAN SIZE; OXIDATIVE STRESS; PATHOLOGY; PATIENT SELECTION; PERICARDIUM; RADIOGRAPHY; REGRESSION ANALYSIS; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; ORGAN SIZE; OXIDATIVE STRESS; PATIENT SELECTION; PERICARDIUM; REGRESSION ANALYSIS; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 77951666172     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.343     Document Type: Article

References (39)

1. Musaad S, Haynes EN. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 2007;29:98-114.
2. Paoletti R, Gotto AM Jr, Hajjar D P. Inflammation in atherosclerosis and implications for therapy. Circulation 2004;109(23 Suppl 1):III20-26.
3. Keaney JF Jr, Larson MG, Vasan RS et al.; Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434-439. (Pubitemid 36337219)
4. Pou KM, Massaro JM, Hoffmann U et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007;116:1234-1241.
5. Carr DB, Utzschneider KM, Hull RL et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-2094.
6. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
7. Rexrode KM, Carey VJ, Hennekens CH et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-1848.
8. Ho E, Shimada Y. Formation of the epicardium studied with the scanning electron microscope. Dev Biol 1978;66:579-585.
9. Moore KL, Persaud TVN. The Developing Human. Clinically Oriented Embryology, 7th edn. Saunders: Philadelphia, 2003, p. 189.
10. Rosito GA, Massaro JM, Hoffmann U et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008;117:605-613.
11. Corradi D, Maestri R, Callegari S et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004;13:313-316.
12. Kankaanpää M, Lehto HR, Pärkkä JP et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006;91:4689-4695.
13. Taguchi R, Takasu J, Itani Y et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 2001;157:203-209.
14. Sironi AM, Gastaldelli A, Mari A et al. Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension 2004;44: 127-133.
15. Sironi AM, Pingitore A, Ghione S et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 2008;51:282-288.
16. Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Subepicardial adipose tissue and the presence and severity of coronary artery disease. Atherosclerosis 2006;186:354-359.
17. de Vos AM, Prokop M, Roos CJ et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J 2008;29:777-783.
18. Iacobellis G, Assael F, Ribaudo MC et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:304-310.
19. Iacobellis G, Ribaudo MC, Assael F et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003;88:5163-5168.
20. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci C V, Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004;94:1084-1087.
21. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004;110:380-385.
22. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol, B 1989;94:225-232.
23. Barandier C, Montani J P, Yang Z. Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. Am J Physiol Heart Circ Physiol 2005;289: H1807-H1813.
24. Mazurek T, Zhang L, Zalewski A et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003;108:2460-2466.
25. Henrichot E, Juge-Aubry CE, Pernin A et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 2005;25:2594-2599.
26. Baker AR, Silva N F, Quinn DW et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006;5: 1.
27. Cheng KH, Chu CS, Lee KT et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond) 2008;32:268-274.
28. Iacobellis G, Pistilli D, Gucciardo M et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005;29:251-255.
29. Kremen J, Dolinkova M, Krajickova J et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006;91:4620-4627.
30. Radeau T, Robb M, Lau P, Borthwick J, McPherson R. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis 1998;139: 369-376. (Pubitemid 28361822)
31. Schoof E, Stuppy A, Harig F et al. Comparison of leptin gene expression in different adipose tissues in children and adults. Eur J Endocrinol 2004;150:579-584.
32. Aronson D, Bartha P, Zinder O et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 2004;28:674-679. (Pubitemid 38580975)
33. Cracowski JL, Durand T. Cardiovascular pharmacology and physiology of the isoprostanes. Fundam Clin Pharmacol 2006;20:417-427.
34. Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27:15-26.
35. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
36. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-1772.
37. Zethelius B, Berglund L, Sundström J et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107-2116.
38. Bastelica D, Mavri A, Verdierl M et al. Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFalpha receptors to PAI-1 levels. Thromb Haemost 2002;88:481-487.
39. Proudfoot J, Barden A, Mori TA et al. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal Biochem 1999;272:209-215.